Horror fans declare ‘childhood trauma is back’ after Final Destination sequel trailer drops
The upcoming sequel to the iconic franchise will be released in May, following a new batch of victims as they attempt to ...
optics.org8 小时
Alcon lines up Lensar deal to expand laser cataract surgery options
Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...
Zacks Investment Research on MSN12 小时
Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval
Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) ...
Zacks Investment Research on MSN12 小时
ALC Stock Rises Following the Merger Agreement With LENSAR
Alcon ALC and LENSAR, Inc. LNSR, a global medical technology company focused on advanced laser solutions for the treatment of cataracts, recently entered into a definitive merger agreement. Per the ...
PharmiWeb14 小时
Alcon Agrees to Acquire LENSAR, Inc.
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on advanced laser ...
The Print15 小时
Glaucoma Prevalence in Asia on the Rise – Medical Community Advocates for Early Screening
Glaucoma is an eye condition that damages the optic nerve, leading to irreversible vision loss. Glaucoma affects ...